SciSparc Ltd.
SciSparc is a specialty pharmaceutical company developing unique cannabinoid technologies for the treatment of central nervous system disorders. Their pipeline includes drug candidates in clinical trials for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s Disease, Agitation, and Autism Spectrum Disorder. The company focuses on improving the lives of those suffering from central nervous system disorders.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Website Highlights
🌟 Similar Trusted Businesses
Addex Therapeutics Ltd.
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Their pipeline includes compounds targeting post-stroke recovery, substance use disorder and chronic cough. The company utilizes its expertise in allosteric modulation for drug discovery.
SERVIER OUTRE-MER
Servier is an independent international pharmaceutical company focused on therapeutic progress for patients. They invest significantly in research and development, particularly in oncology, cardiometabolism, and neuroscience. Servier is known for its long-term vision and commitment to patients' needs.
AGILERA PHARMA AS
Agilera is a leading CDMO contributing to technology development and growth in the radiopharmaceutical market. They offer the entire value chain for the development of new radiopharmaceuticals, from the preclinical phase to commercial production and global distribution. Agilera is approved as a manufacturer for the USA, Japan, Europe, Latin America, and China.